Assisted Reproductive Technology Market Size, Share, Growth Analysis, By Technique(In Vitro Fertilization, Artificial Insemination, Frozen Embryo Transfer, Others), By Procedure, By End User, By Region - Industry Forecast 2024-2031

Global assisted reproductive market was valued at USD 25.30 billion in 2022 and is expected to rise from USD 26.67 billion in 2023 to reach a value of USD 40.67 billion by 2031, at a CAGR of 5.40% during the forecast period (2024-2031).

The global assisted reproductive technology (ART) market is experiencing notable growth, driven by several key factors. Rising infertility rates, advances in medical technology, and increasing awareness and acceptance of ART procedures are major contributors to this expansion. Changing lifestyles, delayed pregnancies, environmental influences, and various medical conditions are leading more individuals to seek fertility treatments, thereby boosting the demand for ART procedures such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and gamete donation. The introduction of innovative technologies, such as time-lapse imaging systems and improved embryo culture media with enhanced composition and stability, has significantly increased the success rates of ART procedures. These advancements help in better monitoring and optimizing embryo development, which in turn improves outcomes. Additionally, the growing acceptance of ART is fueling market growth. Historically, social stigma surrounding infertility and ART procedures created barriers to their use. However, shifting societal attitudes, along with educational initiatives and support groups, have helped normalize ART as a legitimate and effective option for couples facing infertility challenges. This increased acceptance has led to more individuals pursuing fertility treatments, thereby driving the demand for ART services and further expanding the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Assisted Reproductive market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Assisted Reproductive Market Segmental Analysis

The assisted reproductive technology (ART) market is segmented by type, application, and region. Based on type, the market can be segmented into in vitro fertilization (IVF) (fresh donor, frozen donor, fresh non-donor, frozen non-donor), artificial insemination (intrauterine insemination, intracervical insemination, intravaginal insemination, intratubal insemination) and surrogacy. Based on end use, the market is segmented into fertility clinics, hospitals, specialized ART centers, and research institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Assisted Reproductive Market

The global assisted reproductive technology (ART) market is expanding significantly due to rising infertility rates worldwide. Factors such as changing lifestyles, delayed pregnancies, and environmental influences contribute to the increasing demand for ART. These technologies provide solutions for individuals and couples facing fertility challenges, helping them achieve their goal of conceiving.

Restraints in the Global Assisted Reproductive Market

Ethical and legal concerns present significant challenges for the ART market, especially in certain regions. The application of ART procedures raises various ethical issues and is subject to diverse regulations. Key concerns include the appropriate disposal of embryos, the extent of donor anonymity, and the regulation of emerging techniques such as gamete and embryo editing. These issues can affect the availability and acceptance of specific ART procedures and, consequently, influence market dynamics.

Market Trends of the Global Assisted Reproductive Market

A notable trend in the global Assisted Reproductive Technology (ART) market is the rising demand for advanced genetic testing and screening technologies. As reproductive medicine progresses, there is an increasing focus on ensuring the health and viability of embryos before implantation. Techniques like preimplantation genetic screening (PGS) and preimplantation genetic diagnosis (PGD) are becoming more prominent as they help identify genetic abnormalities and chromosomal disorders in embryos. This trend is fueled by couples' desire for healthy children and growing awareness of how genetic testing can enhance the success rates of ART procedures.